These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12610512)

  • 1. Polymorphism of the insulin gene is associated with increased prostate cancer risk.
    Ho GY; Melman A; Liu SM; Li M; Yu H; Negassa A; Burk RD; Hsing AW; Ghavamian R; Chua SC
    Br J Cancer; 2003 Jan; 88(2):263-9. PubMed ID: 12610512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific longevity associations defined by Tyrosine Hydroxylase-Insulin-Insulin Growth Factor 2 haplotypes on the 11p15.5 chromosomal region.
    De Luca M; Rose G; Bonafè M; Garasto S; Greco V; Weir BS; Franceschi C; De Benedictis G
    Exp Gerontol; 2001 Nov; 36(10):1663-71. PubMed ID: 11672987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of gastric cancer with tyrosine hydroxylase gene polymorphism in a northwestern Chinese population.
    Li ZQ; Yu WP; Xie XD; Li PQ; Guo TK; Zhang WH; An LZ; Wang XL
    Clin Exp Med; 2007 Sep; 7(3):98-101. PubMed ID: 17972051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DraI and PstI RFLPs in the tyrosine hydroxylase (TH) and insulin gene (INS) region of chromosome 11.
    Sten-Linder M; Granqvist M; Stern I; Bell GI; Luthman H
    Nucleic Acids Res; 1989 Jul; 17(14):5873. PubMed ID: 2569725
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes susceptibility at IDDM2 cannot be positively mapped to the VNTR locus of the insulin gene.
    Doria A; Lee J; Warram JH; Krolewski AS
    Diabetologia; 1996 May; 39(5):594-9. PubMed ID: 8739920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in IGF-2 as a surrogate marker for predisposition towards tobacco chewing-mediated oral cancer.
    Kaur R; Nagpal JK; Das BR
    Tumour Biol; 2005; 26(3):147-52. PubMed ID: 15970649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
    Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
    Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA polymorphisms in the human tyrosine hydroxylase/insulin/insulin-like growth factor II chromosomal region in relation to glucose and insulin responses.
    Sten-Linder M; Wedell A; Iselius L; Efendic S; Luft R; Luthman H
    Diabetologia; 1993 Jan; 36(1):25-32. PubMed ID: 8094694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INSPstI polymorphism and prostate cancer in African-American men.
    Claeys GB; Sarma AV; Dunn RL; Zuhlke KA; Beebe-Dimmer J; Montie JE; Wojno KJ; Schottenfeld D; Cooney KA
    Prostate; 2005 Sep; 65(1):83-7. PubMed ID: 15880482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk.
    Neuhausen SL; Slattery ML; Garner CP; Ding YC; Hoffman M; Brothman AR
    Prostate; 2005 Jul; 64(2):168-74. PubMed ID: 15678496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11.
    Gu D; O'Dell SD; Chen XH; Miller GJ; Day IN
    Hum Genet; 2002 Feb; 110(2):173-81. PubMed ID: 11935324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility.
    Julier C; Hyer RN; Davies J; Merlin F; Soularue P; Briant L; Cathelineau G; Deschamps I; Rotter JI; Froguel P
    Nature; 1991 Nov; 354(6349):155-9. PubMed ID: 1944595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity.
    O'Dell SD; Bujac SR; Miller GJ; Day IN
    Eur J Hum Genet; 1999; 7(7):821-7. PubMed ID: 10573016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The INS 5' variable number of tandem repeats is associated with IGF2 expression in humans.
    Paquette J; Giannoukakis N; Polychronakos C; Vafiadis P; Deal C
    J Biol Chem; 1998 Jun; 273(23):14158-64. PubMed ID: 9603916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental imprinting effect at the INS-IGF2 diabetes susceptibility locus.
    Polychronakos C; Kukuvitis A; Giannoukakis N; Colle E
    Diabetologia; 1995 Jun; 38(6):715-9. PubMed ID: 7672495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tyrosine hydroxylase and insulin genes are contiguous on chromosome 11.
    O'Malley KL; Rotwein P
    Nucleic Acids Res; 1988 May; 16(10):4437-46. PubMed ID: 2898127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Abd Elbary EH; Abo Warda MH; Hegazy O
    Cytokine; 2014 Jul; 68(1):50-8. PubMed ID: 24656929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
    Narita S; Tsuchiya N; Wang L; Matsuura S; Ohyama C; Satoh S; Sato K; Ogawa O; Habuchi T; Kato T
    Int J Cancer; 2004 Dec; 112(5):872-6. PubMed ID: 15386377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.